MOTS-c Peptide Dosage Chart, Guide and Calculator

[Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy.]

MOTS-c (or Mitochondrial Open Reading Frame of the 12S rRNA type-c) has sparked interest as a promising peptide in metabolic research, with potential applications ranging from weight management to athletic performance. 

Our complete MOTS-c dosage guide provides all the details on dosing protocols, administration techniques, and calculation methods for researchers and healthcare practitioners working with this mitochondrial-derived peptide.

MOTS-c: The Mitochondrial-Derived Peptide

MOTS-c is a 16-amino acid peptide encoded by the mitochondrial 12S rRNA gene that plays a role in energy metabolism regulation. As a mitochondrial-derived peptide (MDP), it is activated in response to stress, exercise, and aging, helping the body maintain metabolic balance and reduce inflammation.

The sequence of MOTS-c (MRWQEMGYIFYPRKLR) is highly conserved among various species, indicating its fundamental biological importance. It functions primarily by activating the AMPK (AMP-activated protein kinase) pathway, a master regulator of cellular energy homeostasis.

With aging, natural MOTS-c levels decline, potentially contributing to insulin resistance, metabolic disorders, and weight gain.

Potential Benefits of MOTS-c

Research suggests MOTS-c may offer several potential benefits:

• Weight reduction and improved metabolic health through increased energy expenditure and fat breakdown¹
• Enhanced glucose regulation and insulin sensitivity, particularly in skeletal muscle²
• Improved physical performance and exercise capacity²
• Anti-inflammatory effects through inhibition of MAP kinase pathways¹
• Potential anti-aging properties and longevity benefits¹

MOTS-c Dosage Chart and Protocols

Various dosing protocols have been proposed based on research findings and clinical experience. Here are the commonly referenced dosing strategies.

Standard Dosage Chart for Different Applications

Purpose	Dosage Range	Frequency	Administration Route
General Use	5-10 mg	1x daily	Subcutaneous injection
Metabolic Health	10-15 mg	1x daily	Subcutaneous injection
Exercise Performance	10-20 mg	1x daily	Subcutaneous injection
Research Applications	0.5-1.0 mg/kg	As per protocol	Subcutaneous/Intraperitoneal

Example Dosing Protocols

Different specific protocols have been developed based on research and clinical experience:

Protocol Example 1:

• Dosage: 0.5mg (0.5ml or 50 units) subcutaneously
• Frequency: Twice weekly
• Duration: 4-6 weeks
• Notes: Treatment can be repeated 2-3 times per year

Protocol Example 2:

• Dosage: 5mg in the morning, preferably before exercise
• Frequency: Every five days
• Duration: 20 days (4 total doses)
• Notes: Can be repeated as needed

Protocol Example 3:

• Dosage: 10mg subcutaneously
• Frequency: 3 times per week (e.g., Monday, Wednesday, Friday)
• Duration: Not specified

Protocol Example 4:

• Dosage: 10mg subcutaneously
• Frequency: Once weekly, ideally before endurance exercise
• Duration: Up to 10 consecutive weeks
• Notes: Recommended once yearly

Protocol Example 5:

• Dosage: 5mg subcutaneously
• Frequency: 3 times weekly (Monday-Wednesday-Friday)
• Duration: 4-6 weeks, followed by once-weekly 5mg for 4 weeks

Protocol Example 6:

• Dosage: 10mg subcutaneously into the abdomen
• Frequency: Once weekly
• Duration: 4 weeks, followed by a second 4-week cycle within a 12-month period

MOTS-c Reconstitution Guide

Proper reconstitution is critical for accurate dosing of MOTS-c peptide.

Reconstitution Procedure

1. Start with lyophilized (freeze-dried) MOTS-c powder in a sealed vial
2. Use bacteriostatic water for reconstitution (preservative-free sterile water can be used but has a shorter shelf life)
3. Standard reconstitution ratio: 1ml of bacteriostatic water per 10mg vial
4. For a 5mg vial, use 0.5ml of bacteriostatic water
5. Add water slowly, allowing it to trickle down the side of the vial
6. Gently swirl to mix; avoid shaking to prevent peptide degradation

Dosage Calculation Formula

The basic formula for calculating the required volume for injection is:

Required volume (mL) = Desired dose (mcg) / Concentration (mcg/mL)

Where:

• Concentration = Total amount of peptide (mcg) / Total volume of solution (mL)

For example:

• If you have 5mg (5000mcg) of MOTS-c reconstituted with 3mL of water
• Concentration = 5000mcg / 3mL = 1666.67mcg/mL
• For a 250mcg dose: Required volume = 250mcg / 1666.67mcg/mL = 0.15mL (15 units on an insulin syringe)

MOTS-c Peptide Dosage Calculator

To accurately calculate your MOTS-c dosage:

1. Determine peptide strength: Identify the total amount of MOTS-c in your vial (e.g., 5mg, 10mg)
2. Choose reconstitution volume: Decide how much bacteriostatic water to add (typically 1mL per 10mg)
3. Calculate concentration: Divide total peptide amount (in mcg) by total solution volume (in mL)
4. Determine desired dose: Based on protocol being followed (e.g., 250mcg, 5mg, 10mg)
5. Calculate required volume: Divide desired dose by concentration calculated in step 3

Example Calculation

For a 10mg MOTS-c vial reconstituted with 1mL of bacteriostatic water:

• Concentration: 10,000mcg ÷ 1mL = 10,000mcg/mL
• For a 5mg dose: 5,000mcg ÷ 10,000mcg/mL = 0.5mL (50 units on insulin syringe)

Our online calculator can assist with this process.

Administration Guidelines and Considerations

MOTS-c is administered via subcutaneous injection, meaning it is injected into the fatty tissue just below the skin. It is not effective as an oral supplement due to digestive breakdown.

Common Injection Sites

• Abdomen (at least 1 inch away from navel)
• Thigh
• Upper arm
• Rotate injection sites to prevent irritation

Storage Requirements

• Store lyophilized (unreconstituted) powder at -20°C (-4°F)
• Once reconstituted, store in refrigerator (2-8°C or 36-46°F)
• Avoid repeated freezing and thawing

Safety and Potential Side Effects

While MOTS-c shows promise in research settings, several important safety considerations should be noted:

• Not approved by major regulatory bodies for human use
• Legal status varies by country and jurisdiction
• Banned by major anti-doping agencies for competitive athletes
• Limited human safety data exists
• Potential side effects include injection site reactions, nausea, headache, and fatigue

Who Should Be Cautious?

• Pregnant or nursing individuals
• People with chronic health conditions
• Minors
• Individuals on prescription medications, especially those affecting metabolism, hormones, or blood sugar

The Bottom Line

MOTS-c represents a promising area of peptide research with potential applications in metabolic health, exercise performance, and age-related conditions.

The dosage protocols outlined in this report reflect current research and recommendations, though it’s important to note that optimal dosing may vary between individuals.

For researchers and healthcare practitioners working with MOTS-c, proper reconstitution, accurate dosage calculation, and appropriate administration are essential for safety and efficacy.

As research continues to evolve, these guidelines may be refined to better harness the potential benefits of this mitochondrial-derived peptide.

When considering MOTS-c research, it remains crucial to approach with scientific rigor and adhere to appropriate regulatory frameworks governing peptide research in respective jurisdictions.

References

1. Zheng, Y., Wei, Z., & Wang, T. (2023). MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Frontiers in endocrinology, 14, 1120533. https://doi.org/10.3389/fendo.2023.1120533 ↩︎
2. Reynolds, J. C., Lai, R. W., Woodhead, J. S. T., Joly, J. H., Mitchell, C. J., Cameron-Smith, D., Lu, R., Cohen, P., Graham, N. A., Benayoun, B. A., Merry, T. L., & Lee, C. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature communications, 12(1), 470. https://doi.org/10.1038/s41467-020-20790-0 ↩︎